Cargando…

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity

Background: In chronic inflammatory demyelinating polyneuropathy (CIDP), there is an urgent need for biomarkers to monitor ongoing disease activity. Serum calprotectin (CLP) induces signaling pathways involved in inflammatory processes and has been shown to correlate with markers of disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stascheit, Frauke, Hotter, Benjamin, Klose, Sarah, Meisel, Christian, Meisel, Andreas, Klehmet, Juliane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473624/ https://www.ncbi.nlm.nih.gov/pubmed/34589050 http://dx.doi.org/10.3389/fneur.2021.723009

Ejemplares similares

Calprotectin as potential novel biomarker in myasthenia gravis
por: Stascheit, Frauke, et al.
Publicado: (2021)

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
por: Diederich, Jan-Markus, et al.
Publicado: (2018)

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy
por: Klehmet, Juliane, et al.
Publicado: (2019)

Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case–Control study
por: Stascheit, Frauke, et al.
Publicado: (2023)

IL-6 Plasma Levels Correlate With Cerebral Perfusion Deficits and Infarct Sizes in Stroke Patients Without Associated Infections
por: Hotter, Benjamin, et al.
Publicado: (2019)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Chronic Inflammatory Demyelinating Polyneuropathy in Patients With Crohn’s Disease on Infliximab Therapy
por: Almuntashri, Fahad, et al.
Publicado: (2021)

Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
por: Klehmet, Juliane, et al.
Publicado: (2023)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Diabetes Mellitus: A Diagnostic Dilemma
por: Valentin, Marcos, et al.
Publicado: (2022)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Overview, Treatment, and a Case Study
por: Ponnala, Madhusudhan, et al.
Publicado: (2023)

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study
por: Koszewicz, Magdalena, et al.
Publicado: (2021)

Inflammatory and stress markers predicting pneumonia, outcome, and etiology in patients with stroke: Biomarkers for predicting pneumonia, functional outcome, and death after stroke
por: Hotter, Benjamin, et al.
Publicado: (2020)

Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy
por: Alcantara, Monica, et al.
Publicado: (2022)

Acute Inflammatory Demyelinating Polyneuropathy With Bowel and Bladder Incontinence Following COVID-19 Infection
por: Letchuman, Vijay, et al.
Publicado: (2021)

A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy
por: Patel, Dhaval, et al.
Publicado: (2022)

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
por: Kira, Jun-ichi
Publicado: (2021)

Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
por: Klehmet, Juliane, et al.
Publicado: (2017)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
por: Alsolaihim, Alanood, et al.
Publicado: (2020)

Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey
por: Hashimoto, Yu, et al.
Publicado: (2018)

Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)

67/m mit neu aufgetretener Dysarthrie und Dysphagie sowie COVID-19 („coronavirus disease 2019“): Vorbereitungskurs Neurologische Intensivmedizin: Fall 23
por: Neumann, B., et al.
Publicado: (2022)

Electrophysiological Responsiveness to Long-Term Therapy in Chronic Inflammatory Demyelinating Polyneuropathy: Case Report
por: Khomand, Payam, et al.
Publicado: (2020)

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)

Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018)

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
por: Bril, Vera, et al.
Publicado: (2016)

Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple Sclerosis
por: Auer, Michael, et al.
Publicado: (2022)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
por: Fatehi, Farzad, et al.
Publicado: (2013)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015)

Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
por: Stettner, Mark, et al.
Publicado: (2015)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020)

Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy
por: Chaudhary, Umair J., et al.
Publicado: (2020)

Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy
por: Goyal, Namita A., et al.
Publicado: (2021)

Peripheral Nerve Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tanitame, Keizo, et al.
Publicado: (2020)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tan, Cheng-Yin, et al.
Publicado: (2023)

Axonal loss at time of diagnosis as biomarker for long‐term disability in chronic inflammatory demyelinating polyneuropathy
por: Al‐Zuhairy, Ali, et al.
Publicado: (2022)

Chronic Inflammatory Demyelinating Polyneuropathy Variant with Creatine-Kinase Elevation and Vanishing Effect of Immunoglobulins
por: Finsterer, Josef, et al.
Publicado: (2017)

Dilemmas in Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A New Axonal Variant?
por: Sharma, Sanjiv, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_se6bt65okg16n82l6i6mqghn27